Clinical impact of 18F-FDG-PET/CT in detecting asymptomatic recurrence in the surveillance of patients with lymphoma

被引：0
|
作者：
Gonzalez Garcia, B. [1 ]
Bellon Guardia, M. E. [1 ]
Palomar Munoz, A. [1 ]
Garcia Vicente, A. M. [1 ]
Talavera Rubio, P. [1 ]
Poblete Garcia, V. M. [1 ]
Pilkington Woll, P. [1 ]
Nunez Garcia, A. [1 ]
Cordero Garcia, J. M. [1 ]
Cepedello Boiso, I. [1 ]
Soriano Castrejon, A. [1 ]
机构：
[1] Gen Hosp, Dept Nucl Med, Ciudad Real, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S435 / S435
页数：1
相关论文
共 50 条
  • [21] The clinical impact of 18F-FDG PET/CT in Hodgkin lymphoma
    Molnar, Z.
    Deak, B.
    Lengyel, Z.
    Molnar, P.
    Rosta, A.
    Schneider, T.
    Szaleczky, E.
    Varga, F.
    Varady, E.
    Borbely, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S434 - S434
  • [22] Clinical relevance of 18F-FDG-PET/CT incidental findings
    Hadad, Zeina Sahib Hussain
    Afzelius, Pia
    Sorensen, Sten Mellerup
    Jurik, Anne Grethe
    DANISH MEDICAL JOURNAL, 2020, 67 (10):
  • [23] Intussusception Caused by an Ileocecal Lymphoma Disclosed on 18F-FDG-PET/CT
    Ha-Kawa, Sangkil
    Ueno, Yasuhiro
    INTERNAL MEDICINE, 2013, 52 (07) : 827 - 828
  • [24] Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
    Ozkan, Elgin
    Soydal, Cigdem
    Kucuk, Ozlem N.
    Ibis, Erkan
    Erbay, Guner
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (12) : 1162 - 1168
  • [25] Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
    Ozkan, E.
    Soydal, C.
    Kucuk, O. N.
    Ibis, E.
    Erbay, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S347 - S347
  • [26] Impact of 18F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma
    Ozkan, Elgin
    Soydal, Cigdem
    Kucuk, Ozlem N.
    Ibis, Erkan
    Erbay, Guner
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [27] Impact of 18F-FDG-PET/CT in the management of suspected RAI refractory DTC persistence/recurrence
    Lodi Rizzini, E.
    Zanoni, L.
    Tabacchi, E.
    Repaci, A.
    Scampoli, C.
    Vallerossa, D.
    Laghi, V.
    Cavallini, L.
    Razganiayeva, N.
    Cardano, R.
    Scirocco, E.
    Cammelli, S.
    Frezza, G. P.
    Morganti, A. G.
    Fanti, S.
    Monari, F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S851 - S852
  • [28] 18F-FDG PET/CT in the clinical management of patients with lymphoma
    Tamayo, P.
    Martin, A.
    Diaz, L.
    Cabrero, M.
    Garcia, R.
    Garcia-Talavera, P.
    Caballero, D.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (05): : 312 - 321
  • [29] Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic review
    Amit Singnurkar
    Raymond Poon
    Ur Metser
    Annals of Nuclear Medicine, 2017, 31 : 366 - 378
  • [30] Comparison of 18F-FDG-PET/MRI and 18F-FDG-PET/CT for initial staging in pulmonary carcinoma
    Luetje, S.
    Ruhlmann, V.
    Bellendorf, A.
    Poeppel, T. D.
    Beiderwellen, K.
    Heusch, P.
    Schaarschmidt, B. M.
    Quick, H. H.
    Nagarajah, J.
    Gomez, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S439 - S440
12345